BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35724769)

  • 41. COVID-19 in Patients with CKD in New York City.
    Akchurin O; Meza K; Biswas S; Greenbaum M; Licona-Freudenstein AP; Goyal P; Choi JJ; Choi ME
    Kidney360; 2021 Jan; 2(1):63-70. PubMed ID: 33629075
    [TBL] [Abstract][Full Text] [Related]  

  • 42. COVID-19 and cardiovascular disease in patients with chronic kidney disease.
    Del Vecchio L; Balafa O; Dounousi E; Ekart R; Fernandez BF; Mark PB; Sarafidis P; Valdivielso JM; Ferro CJ; Mallamaci F
    Nephrol Dial Transplant; 2024 Jan; 39(2):177-189. PubMed ID: 37771078
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study.
    Clift AK; Coupland CAC; Keogh RH; Diaz-Ordaz K; Williamson E; Harrison EM; Hayward A; Hemingway H; Horby P; Mehta N; Benger J; Khunti K; Spiegelhalter D; Sheikh A; Valabhji J; Lyons RA; Robson J; Semple MG; Kee F; Johnson P; Jebb S; Williams T; Hippisley-Cox J
    BMJ; 2020 Oct; 371():m3731. PubMed ID: 33082154
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Kidney health in the COVID-19 pandemic: An umbrella review of meta-analyses and systematic reviews.
    Yang L; Li J; Wei W; Yi C; Pu Y; Zhang L; Cui T; Ma L; Zhang J; Koyner J; Zhao Y; Fu P
    Front Public Health; 2022; 10():963667. PubMed ID: 36172213
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic.
    Banerjee A; Chen S; Pasea L; Lai AG; Katsoulis M; Denaxas S; Nafilyan V; Williams B; Wong WK; Bakhai A; Khunti K; Pillay D; Noursadeghi M; Wu H; Pareek N; Bromage D; McDonagh TA; Byrne J; Teo JTH; Shah AM; Humberstone B; Tang LV; Shah ASV; Rubboli A; Guo Y; Hu Y; Sudlow CLM; Lip GYH; Hemingway H
    Eur J Prev Cardiol; 2021 Dec; 28(14):1599-1609. PubMed ID: 33611594
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cardiovascular outcomes in patients with chronic kidney disease and COVID-19: a multi-regional data-linkage study.
    Lambourg EJ; Gallacher PJ; Hunter RW; Siddiqui M; Miller-Hodges E; Chalmers JD; Pugh D; Dhaun N; Bell S
    Eur Respir J; 2022 Nov; 60(5):. PubMed ID: 35551093
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence and Impact of Preexisting Comorbidities on Overall Clinical Outcomes of Hospitalized COVID-19 Patients.
    Koyyada R; Nagalla B; Tummala A; Singh AD; Patnam S; Barigala R; Kandala M; Krishna V; Manda SV
    Biomed Res Int; 2022; 2022():2349890. PubMed ID: 35402606
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study.
    Ge E; Li Y; Wu S; Candido E; Wei X
    PLoS One; 2021; 16(10):e0258154. PubMed ID: 34610047
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Covid-19 pandemic in patients with chronic kidney disease].
    Araeipour-Tehrani Y; Haidar F; Saudan P
    Rev Med Suisse; 2021 Feb; 17(727):389-393. PubMed ID: 33625804
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risks and Benefits of Kidney Transplantation during the COVID-19 Pandemic: Transplant or Not Transplant?
    Ajaimy M; Liriano-Ward L; Graham JA; Akalin E
    Kidney360; 2021 Jul; 2(7):1179-1187. PubMed ID: 35368354
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mortality in chronic kidney disease patients with COVID-19: a systematic review and meta-analysis.
    Cai R; Zhang J; Zhu Y; Liu L; Liu Y; He Q
    Int Urol Nephrol; 2021 Aug; 53(8):1623-1629. PubMed ID: 33389508
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk prediction of covid-19 related death or hospital admission in adults testing positive for SARS-CoV-2 infection during the omicron wave in England (QCOVID4): cohort study.
    Hippisley-Cox J; Khunti K; Sheikh A; Nguyen-Van-Tam JS; Coupland CAC
    BMJ; 2023 Jun; 381():e072976. PubMed ID: 37343968
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.
    Zuccon W; Comassi P; Adriani L; Bergamaschini G; Bertin E; Borromeo R; Corti S; De Petri F; Dolci F; Galmozzi A; Gigliotti A; Gualdoni L; Guerra C; Khosthiova A; Leati G; Lupi G; Moscato P; Perotti V; Piantelli M; Ruini A; Sportelli S; Susca M; Troiano C; Benelli G; Buscarini E; Canetta C; Merli G; Scartabellati A; Melilli B S C G; Sfogliarini R; Pellegatta G; Viganò G
    Am J Emerg Med; 2021 Jul; 45():156-161. PubMed ID: 33046317
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Impact of COVID-19 Infection on Patients with Chronic Diseases Admitted to ICU: a Cohort Retrospective Study.
    Alammari F; Al-Sowayan BS; Albdah B; Alsubait AA
    J Epidemiol Glob Health; 2023 Jun; 13(2):313-321. PubMed ID: 37199912
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In-hospital adverse outcomes and risk factors among chronic kidney disease patients infected with the omicron variant of SARS-CoV-2: a single-center retrospective study.
    Guo Y; Guo Y; Ying H; Yu W; Chen S; Zhang Y; Zhang S; Lin Y; Sun F; Zhang Y; Yu J; Ma K; Qin L; Long F; Zhu H; Mao R; Xue J; Zhang J
    BMC Infect Dis; 2023 Oct; 23(1):698. PubMed ID: 37853317
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessing COVID-19 pandemic policies and behaviours and their economic and educational trade-offs across US states from Jan 1, 2020, to July 31, 2022: an observational analysis.
    Bollyky TJ; Castro E; Aravkin AY; Bhangdia K; Dalos J; Hulland EN; Kiernan S; Lastuka A; McHugh TA; Ostroff SM; Zheng P; Chaudhry HT; Ruggiero E; Turilli I; Adolph C; Amlag JO; Bang-Jensen B; Barber RM; Carter A; Chang C; Cogen RM; Collins JK; Dai X; Dangel WJ; Dapper C; Deen A; Eastus A; Erickson M; Fedosseeva T; Flaxman AD; Fullman N; Giles JR; Guo G; Hay SI; He J; Helak M; Huntley BM; Iannucci VC; Kinzel KE; LeGrand KE; Magistro B; Mokdad AH; Nassereldine H; Ozten Y; Pasovic M; Pigott DM; Reiner RC; Reinke G; Schumacher AE; Serieux E; Spurlock EE; Troeger CE; Vo AT; Vos T; Walcott R; Yazdani S; Murray CJL; Dieleman JL
    Lancet; 2023 Apr; 401(10385):1341-1360. PubMed ID: 36966780
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Demographics, clinical characteristics, and outcomes of 27,256 hospitalized COVID-19 patients in Kermanshah Province, Iran: a retrospective one-year cohort study.
    Hesni E; Sayad B; Khosravi Shadmani F; Najafi F; Khodarahmi R; Rahimi Z; Bozorgomid A; Sayad N
    BMC Infect Dis; 2022 Mar; 22(1):319. PubMed ID: 35361161
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The aggregate index of systemic inflammation may predict mortality in COVID-19 patients with chronic renal failure.
    Ercan Z; Evren Öztop K; Pınar M; Varim C; Dheir H; Karacaer C; Yaylaci S; Bilal Genç A; Çekiç D; Nalbant A; Cihad Genç A
    Eur Rev Med Pharmacol Sci; 2023 Apr; 27(8):3747-3752. PubMed ID: 37140323
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic.
    Sansone NMS; Boschiero MN; Ortega MM; Ribeiro IA; Peixoto AO; Mendes RT; Marson FAL
    Lancet Reg Health Am; 2022 Apr; 8():100177. PubMed ID: 35018359
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.